‘Essential’ Drug Coverage Including Obesity Treatments Make Sense For ACA Plans, CMS Says
Executive Summary
But the Centers for Medicare and Medicaid Services wants to see data first on how promoting coverage of the new obesity drugs would impact uptake, plan costs and beneficiary premiums.